Pink Bismuth

Quick links to important sections

Pink Bismuth

Method of action: Antacid, Bismuth Containing

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pink Bismuth

Property Description
Active Ingredient Bismuth Subsalicylate
Form Oral Liquid Suspension (primary form), Chewable Tablets
Pharmacological Class Anti-diarrheal Agent, Antisecretory Agent, Adsorbent
Origin Synthetic salt
Route Oral

Pink Bismuth is the widely recognized common name for an Over-the-Counter (OTC) Medication whose active ingredient is Bismuth Subsalicylate. This medication is classified pharmacologically as a triple-action agent, functioning as an Anti-diarrheal Agent, an Antisecretory Agent, and an Adsorbent. This pharmacological profile indicates that the drug targets the digestive system locally, rather than throughout the entire body. The preparation is a synthetic salt, derived from the mineral Bismuth and Salicylic Acid, and is defined as a single-ingredient product in its core formulation.


Bismuth Subsalicylate: The Composition and General Purpose

The medication is composed of the active ingredient Bismuth Subsalicylate, found in popular brand formulations such as Pepto-Bismol and certain Kaopectate products. It is primarily known as an Oral Liquid Suspension, distinctly characterized by its Pink Coloration due to the inclusion of excipients like Bismuth Oxychloride in its Aqueous Suspension base. The drug is also available as solid dose forms, including Chewable Tablets and Caplets, offering patient versatility. The medication's general therapeutic purpose is to mitigate overall Gastrointestinal Distress and discomfort associated with common intestinal imbalances, such as relieving the symptoms of a general Upset Stomach or mild Indigestion. This benefit is rooted in the high-level mechanism where the Bismuth compound provides a Protective Coating on the GI lining and contributes to fluid balance through its Antisecretory Agent function.

Regulatory References

  1. MedlinePlus: Bismuth Subsalicylate Drug Information

What side effects are possible with Pink Bismuth?

The officially documented safety profile for Pink Bismuth (Bismuth Subsalicylate) is characterized by two distinct categories: expected, reversible effects tied to the bismuth compound and rare, serious risks related to the systemic absorption of the salicylate component.

Officially Documented Side Effects

The most common and expected adverse reactions are temporary, harmless changes to appearance classified under Gastrointestinal Disorders. These include the temporary darkening of the stool and darkening of the tongue, which are normal consequences of the bismuth ingredient reacting in the digestive tract. Less common documented effects include constipation and Tinnitus (ringing or buzzing in the ears), the latter of which is related to the absorbed salicylate component.

Safety Considerations and Restrictions

Official regulatory labeling includes explicit safety restrictions and warnings for specific populations and conditions. The medication is contraindicated for use in children and teenagers who have or are recovering from viral illnesses such as chickenpox or the flu, due to the rare but serious risk of Reye's Syndrome linked to the salicylate.

Serious adverse reactions documented in regulatory sources are generally associated with excessive or prolonged use, leading to potential Salicylate Toxicity, symptoms of which may include confusion or severe hearing impairment. The product is also restricted for individuals with a known allergy to salicylates (like aspirin) or those with active gastrointestinal bleeding. The risk of salicylate-related effects, such as tinnitus, is typically associated with the total cumulative dose and duration of treatment, emphasizing the importance of adhering to official duration limits.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose from Pink Bismuth (Bismuth Subsalicylate) is primarily associated with salicylate toxicity, as documented in official regulatory labeling. Early manifestations of toxicity may include ringing in the ears (tinnitus) or hearing loss, which are explicit triggers to discontinue use and seek medical advice. Further acute toxicity can present with central nervous system signs such as confusion, lethargy (severe drowsiness), and vomiting, alongside changes in respiration, such as fast or deep breathing.

Severe or life-threatening outcomes described in regulatory documents include metabolic acidosis, convulsions (seizures), coma, and potential renal dysfunction. Regulatory labels note that elderly patients and those with renal impairment are considered more susceptible to toxicity.

Immediate medical help must be sought for any suspected overdose. Regulators explicitly mandate to contact a Poison Control Center or get medical help right away. In the event the affected person has collapsed, had a seizure, or is unconscious, emergency services must be called immediately. There is no specific antidote known for Bismuth Subsalicylate overdose; management focuses on symptomatic and supportive treatment, with advanced procedures like haemodialysis reserved for severe poisoning cases.

Therapeutic Uses of Pink Bismuth

Pink Bismuth (Bismuth Subsalicylate) is commonly used to help with a range of acute symptoms affecting the gastrointestinal tract.


Symptomatic Relief for Acute Digestive Distress

The medication is commonly used in clinical settings that involve acute or unstable symptom patterns, such as those caused by dietary overload or foreign travel. It is relevant for easing diarrhea and traveler's diarrhea, and may assist with managing associated discomforts such as general upset stomach, indigestion, mild heartburn, and queasiness or nausea. Pink Bismuth helps address symptom clusters that may become intense or disruptive, assisting with maintaining functional stability during these acute episodes.

It is commonly used across conditions presenting with acute episodes where symptoms are related to physical discomfort and systemic imbalance. Pink Bismuth may also be part of symptomatic management in multi-drug regimens for specific gastrointestinal infections.

Quick Fact: Provides support that helps ease the overall symptom burden

Regulatory References

  1. National Institutes of Health (NIH) MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Pink Bismuth (Bismuth Subsalicylate)

Official regulatory information defines specific population eligibility and contraindications for the use of Bismuth Subsalicylate.

Populations Excluded from Use

Contraindications are established based primarily on the drug's salicylate component and its interaction with underlying conditions:

  • Salicylate Sensitivity: Individuals with a known allergy or hypersensitivity to aspirin or other salicylates must not use this medicine.
  • Pediatric Risk: Children and teenagers with or recovering from chickenpox or flu-like symptoms are contraindicated due to the risk of Reye's syndrome.
  • Gastrointestinal Health: Patients with active gastrointestinal ulcers, bleeding problems, or bloody/black stools are excluded.
  • Organ Function: Use is contraindicated in patients with severe renal impairment.

Age and Physiological Restrictions

  • Minimum Age: The Over-the-Counter (OTC) formulation is not for use in children under 12 years of age.
  • Pregnancy and Lactation: Use is not recommended during pregnancy (especially after 20 weeks) or while breastfeeding, as salicylates are excreted into human milk.
  • Conditional Use: Elderly patients and those with conditions like diabetes or gout should consult a healthcare provider before use. The approved population for standard use consists of adults and children 12 years of age and older who do not have any specified contraindications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Pink Bismuth, which contains Bismuth Subsalicylate, based on the actions of its adsorbent and salicylate components. Interactions are generally classified into pharmacodynamic and pharmacokinetic patterns.

Pharmacodynamic and Absorption Interactions

Classification Interacting Agents Official Regulatory Concern
Pharmacodynamic Reinforcement Anticoagulants (e.g., Warfarin), NSAIDs/Salicylates (e.g., Aspirin) Increased risk of bleeding or salicylate-related toxicity due to additive effects.
Antagonism/Enhancement Uricosurics (Gout meds), Oral Antidiabetics Decreased therapeutic effectiveness of Uricosurics; enhanced hypoglycemic effect with Antidiabetics.
Absorption Inhibition Tetracycline Antibiotics (e.g., Doxycycline) Significantly decreased antibiotic exposure due to Bismuth Subsalicylate inhibiting absorption.
Absorption Enhancement Proton Pump Inhibitors (PPIs) (e.g., Omeprazole) Increased systemic Bismuth Subsalicylate exposure.

Interaction-Related Constraints

Certain combinations are subject to restrictions or require specific administration timing. The official labels advise against co-administration with other salicylates or NSAIDs to prevent toxicity. Administration of Tetracycline Antibiotics must be separated from Pink Bismuth doses to maintain the antibiotic’s required plasma levels. Additionally, caution notes exist for elderly patients and those with kidney disease due to increased sensitivity to the salicylate component.

Mechanism of Action

️ Mucosal Protection and Toxin Adsorption

Pink Bismuth (Bismuth subsalicylate) acts locally in the gastrointestinal lumen. The bismuth component forms a protective barrier over mucosal surfaces, resulting in physical protection of the underlying mucosa from luminal contents. It also engages in adsorption, physically binding to and neutralizing certain bacterial enterotoxins and harmful substances; this binding interaction reduces the availability of enterotoxins to engage mucosal receptors.


Modulation of Enteric Secretion

The salicylate part of the compound modulates enteric fluid dynamics through the inhibition of the prostaglandin synthesis pathway. Prostaglandins are lipid mediators that regulate intestinal water and electrolyte transport. By suppressing their local synthesis, the reduced prostaglandin activity lowers the rate of net water and electrolyte transport across the intestinal epithelium.


Localized Antimicrobial Interference

The bismuth component exerts a mild, localized antimicrobial action by interfering with the enzymatic processes and integrity of certain intestinal pathogens. This interference alters the proliferative and pathogenic capabilities of specific microorganisms within the gastrointestinal lumen.

Dosage and Administration Information

How to Use Pink Bismuth

Bismuth Subsalicylate (Pink Bismuth) is administered via the oral route exclusively in its officially approved forms: liquid suspension, chewable tablet, and caplet (swallowable tablet). The standard adult usage patterns are governed by specific quantitative limits and procedural requirements.


Standard Dosing and Frequency

Dosing Parameter Official Instruction (Adults 12 years)
Single Dose 525 mg (equivalent to 30 mL liquid or two 262 mg units)
Frequency Repeat the single dose every \frac12 hour or 1 hour as needed.
Maximum Daily Limit Not to exceed 8 doses (or \mathbf4200 mg) in 24 hours.
Acute Duration Limit Use for not more than 2 days.

Procedural Requirements and Context

Administration of the liquid suspension requires the bottle to be shaken well before use, and the dose must be measured accurately using the provided cup. The caplet form must be swallowed whole with water and must not be chewed; conversely, chewable tablets are designed to be dissolved in the mouth. The medicine may be taken independently of meals.

For patients under 12 years of age, official Over-the-Counter (OTC) labeling states: "Ask a doctor". Although acute symptomatic relief is limited to a short course, the drug is also utilized in specific prescription combination regimens where the duration of use is extended, typically to 10 or 14 days. These official instructions establish the standardized parameters for administration.

Recent Clinical Evidence

Pink Bismuth: Recent Clinical Evidence

Pink bismuth, or bismuth subsalicylate (BSS), is an over-the-counter medication with clinical evidence supporting its use for various gastrointestinal symptoms. Research has focused primarily on its dual-component actions: the bismuth element's antimicrobial activity and the salicylate component's antisecretory effects within the intestine.

Clinical Efficacy Summary

Systematic reviews and meta-analyses have examined the effectiveness of BSS across several indications:

Indication Study Outcome Measures
Acute Diarrhea Studies have observed a greater likelihood of symptom relief in patients receiving BSS compared to placebo. Efficacy has been documented particularly in cases of infectious diarrhea, such as traveler's diarrhea.
H. pylori Eradication BSS is a component of certain quadruple therapy regimens for the eradication of Helicobacter pylori bacteria. Clinical evidence suggests that bismuth-containing regimens may offer benefits over standard triple therapy in settings where antibiotic resistance is a concern.
Upset Stomach/Nausea Clinical trials indicate that BSS provides subjective relief of symptoms associated with indigestion, heartburn, and abdominal discomfort.

Safety Profile and Limitations

BSS is generally considered well-tolerated for short-term use. Clinical data shows the most common expected effects are a temporary and harmless darkening of the stool and/or tongue, caused by the formation of bismuth sulfide in the gastrointestinal tract. Serious neurological symptoms are rare and typically associated with the prolonged, excessive accumulation of salicylates, particularly in individuals with compromised kidney function. Regulatory bodies advise against the use of salicylate-containing products, including BSS, in children and teenagers recovering from viral infections due to the potential association with Reye's syndrome.

Frequently Asked Questions (FAQ)

Common questions about Pink Bismuth (FAQ)

Q: Is Pink Bismuth considered an antacid?

Yes, according to official regulatory documentation, Pink Bismuth is classified as both an antidiarrheal agent and an upset stomach reliever/antacid. This classification reflects its role in relieving symptoms of discomfort and helping to reduce the frequency of bowel movements.


Q: Does Pink Bismuth help with gas and bloating?

Official product documents list the relief of upset stomach symptoms, including gas and belching, among the medicine’s intended uses. The active ingredient, Bismuth Subsalicylate, is indicated to alleviate discomfort associated with fullness, indigestion, and nausea.


Q: Does Pink Bismuth contain any sugar or alcohol?

Many official liquid formulations of Pink Bismuth are explicitly labeled as alcohol-free and sugar-free. These specifications are typically part of the 'Other Information' found on the product's regulatory label.


Q: Does using Pink Bismuth affect the results of an x-ray or other medical test?

Yes, the bismuth component of the medicine may interfere with certain medical tests. Regulatory information states this product can affect x-rays of the intestines, potentially leading to false results for that procedure.


Q: What happens if I forget to take a dose of Pink Bismuth?

The official regulatory label does not contain specific instructions regarding missed doses. Official labeling indicates that users should follow the stated dosing and frequency requirements as specified on the label.


Q: What are the main ingredients in Pink Bismuth besides the active one?

The primary non-active ingredients, known as excipients, vary based on whether the product is a liquid, chewable, or caplet. These ingredients typically include a combination of flavorings, color additives (like D&C Red for the pink color), and stabilizing or binding agents.


Q: Can Pink Bismuth be used to prevent traveler's diarrhea?

The primary indication found on regulatory labels for this medicine is the relief of acute diarrhea symptoms, including traveler’s diarrhea. The label does not explicitly state that the product is intended for the prevention of this condition.


Q: Does Pink Bismuth interact with common pain relievers like Tylenol (acetaminophen)?

Authoritative patient safety guidelines do not typically report concerns regarding the co-administration of Pink Bismuth and acetaminophen (Tylenol). However, specific warnings exist regarding interactions with other types of pain relievers, such as NSAIDs and aspirin, due to the drug’s salicylate content.


Q: What is the role of bismuth in the body after I take this medicine?

The bismuth component of the drug is mostly designed to act locally in the gastrointestinal tract. Official pharmacological data indicates that very little of the bismuth is absorbed into the bloodstream. The absorbed portion is slowly eliminated from the body primarily through urine and bile.


Q: Is Pink Bismuth safe for older adults (seniors)?

The official regulatory label does not include specific safety warnings only for the general elderly population. Official labeling states that consultation with a doctor or pharmacist is described as necessary if the user is already taking medicine for conditions common in seniors, such as diabetes, gout, arthritis, or blood-thinning medication.


Q: Why is the drug commonly associated with a specific color, and is it always pink?

The characteristic pink color in many liquid and chewable forms is due to the inclusion of specific, government-approved color additives (D&C Red dyes) in the formulation. Not all forms are pink, however; the product is also available in colorless or white caplet and tablet forms.


Q: Are there any known side effects that affect the mouth or throat?

Yes, the official regulatory warning states that a temporary, but harmless, darkening of the tongue and/or stool may occur while using the product. This effect is a normal, expected result of the bismuth ingredient reacting in the digestive tract.


Q: Does Pink Bismuth contain gluten or lactose?

Some official liquid formulations are explicitly labeled as gluten-free. Because specific inactive ingredients vary widely between different dose forms, to obtain definitive information on the presence of gluten or lactose, review of the specific product label or packaging is indicated.


Q: How quickly is the active ingredient eliminated from the body?

Elimination rates differ significantly for the two parts of the active ingredient. The salicylate component is eliminated from the body over a period of hours. In contrast, the small amount of absorbed bismuth is eliminated very slowly, with official data indicating a half-life of several weeks.


Q: What should I do if I accidentally take too much Pink Bismuth?

The official product warning states that seeking immediate medical attention is required in case of overdose. This is to ensure prompt contact with a Poison Control Center or other healthcare provider right away.


Q: Can Pink Bismuth mask symptoms of a more serious condition?

The regulatory label addresses this by describing conditions under which the product should be discontinued and a healthcare professional consulted if symptoms worsen or last more than two days. This warning helps prevent the delay of necessary treatment for a more serious, underlying health condition.

How should Pink Bismuth be stored and disposed of?

Official Storage and Disposal Requirements

Bismuth subsalicylate (Pink Bismuth) must be stored according to regulatory labeling to maintain its stability. All forms require storage at room temperature, typically 15 C to 30 C (59 F to 86 F).

Storage Requirement Rule as per Labeling
Temperature Avoid excessive heat (above 40 C) and do not freeze (for liquids).
Container/Handling Keep containers tightly closed and protect tablets from moisture and light.
Safety A mandatory requirement is to Keep out of reach of children.
Disposal Discard the product after its expiration date. Follow general regulatory guidelines for disposal, as the medication is not on the FDA's flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pink Bismuth found in:

A-Z Index: